PFIZER INC recalls Vial Label
- Published
- 27 Aug 2025
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Lack of Assurance of Sterility.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05. Case: NDC 0409-4933-10.
Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 00409-6637-14.
- Brand / company
- PFIZER INC
- Codes / lots
- Lot #: LY3681, LY4360, LY4416, Exp. 02/28/2026 | Lot #: LH2671, Exp. 11/30/2026
- Distribution
- U.S. Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 27 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.